Ravi Ravinuthala, MD
Gastroenterology · Cincinnati, OHNPI 1669461588
Payments from drug & device makers
Across 811 payments — averaging $1039.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intercept Pharmaceuticals, Inc.$253K
- Gilead$246K
- Madrigal Pharmaceuticals$114K
- AbbVie$68K
- Intercept Pharma Europe Ltd.$48K
- Ipsen Pharma SAS$32K
- plus $81K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intercept Pharmaceuticals, Inc. | 122 | $252,872 |
| Gilead | 195 | $246,406 |
| Madrigal Pharmaceuticals | 54 | $113,983 |
| AbbVie(2 entities) | 215 | $68,266 |
| Intercept Pharma Europe Ltd. | 11 | $48,284 |
| Ipsen Pharma SAS | 16 | $32,147 |
| Hoffmann-la Roche Limited | 5 | $20,900 |
| Shionogi Inc | 14 | $17,900 |
| Bausch Health US, LLC | 9 | $15,654 |
| Ipsen Biopharmaceuticals, Inc | 8 | $13,067 |
| Novartis | 8 | $7,760 |
| Dova Pharmaceuticals | 6 | $3,357 |
| Takeda Pharmaceuticals U.S.A., Inc. | 38 | $558 |
| Johnson & Johnson | 32 | $395 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $292 |
| Ironwood Pharmaceuticals, Inc | 11 | $184 |
| Medtronic | 2 | $154 |
| Lilly USA, LLC | 5 | $101 |
| Ferring Pharmaceuticals Inc. | 5 | $87 |
| QOL Medical, LLC | 4 | $81 |
| Sanofi | 3 | $67 |
| Aimmune Therapeutics, Inc. | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Celltrion USA Inc. | 3 | $57 |
| Pfizer | 3 | $51 |
| Merck | 3 | $48 |
| Mallinckrodt Hospital Products Inc. | 2 | $44 |
| Braintree Laboratories, Inc. | 2 | $35 |
| Bristol Myers Squibb | 2 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| UCB, Inc. | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $14 |
| Micro-tech Endoscopy USA, Inc. | 3 | $14 |
How this compares
$842,984 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Cincinnati
- Anita AfzaliCincinnati$2.4M
- Pradeep BekalCincinnati$1.4M
- Loren BrookCincinnati$1.2M
- Kara de FeliceCincinnati$527K
- Vidhya KunnathurCincinnati$456K
- Bruce YacyshynCincinnati$411K
- Allan PeckCincinnati$391K
- Luis LaraCincinnati$314K
- Robert IsfortCincinnati$280K
- Michael KreinesCincinnati$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.